This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is to review the safety of hydroxyurea with regards to severe adverse effects in people with β-thalassaemia major. The second objective is to review the efficacy of hydroxyurea in reducing or ameliorating the requirement of blood transfusions in people with β-thalassaemia major.
ASJC Scopus subject areas
- Pharmacology (medical)